Menu ×

IT & TELECOM

Machine Learning in the Pharmaceutical Industry Market Segmentation by Application (Electronic Recordkeeping, Data Integrity, Predictive Analysis, Radiology, and Others) – Global Demand Analysis & Opportunity Outlook 2030

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More

Global Machine Learning in the Pharmaceutical Industry Market Highlights over 2022 – 2030

The global machine learning in the pharmaceutical industry market is estimated to grow at a robust CAGR over the forecast period, i.e., 2022 – 2030. The growth of the market can be attributed to the increasing amount of big data in the health industry, along with the growth of machine learning. Machine learning is a common form of artificial intelligence (AI), that is extensively used in various end-use industries, such as, BFSI, IT & Telecom, and others. The presence of huge amounts of big data in the pharmaceutical industry, in the form of patient history, clinics and pharmacies records, drug development, and others, is estimated to boost the scope for machine learning in the pharmaceutical industry. With the help of machine learning, it can be possible to predict the result of any drug on a patient, provide personalized treatment, and develop drugs and treatment methods based on patient responses. These beneficial applications of machine learning are estimated to boost the market growth. According to the statistics by the Office of the National Coordinator for Health Information Technology of the United States, as of 2017, around 86% of office-based physicians had adopted electronic health record (HER) system.

Machine Learning in the Pharmaceutical Industry Market

Get more information on this reportDownload Sample PDF

The market is segmented by application into electronic recordkeeping, data integrity, predictive analysis, radiology, and others, out of which, the predictive analysis segment is anticipated to hold the notable share in the market over the forecast period owing to the dire need to predict the biological response of the patient to a certain drug, in order to design better treatment method for the disease. Machine learning can analyze data and overtime predict the possible outcomes. This is estimated to boost the growth of the segment. 

Major Macro-Economic Indicators Impacting the Market Growth

Research Expenditure

The never-ending growth in internet accessibility around the world along with numerous technological advancements comprising 5G, blockchain, cloud services, Internet of Things (IoT), and Artificial Intelligence (AI) among others have significantly boosted the economic growth in the last two decades. As of April 2021, there were more than 4.5 billion users that were actively using the internet globally. Moreover, the growth in ICT sector has significantly contributed towards GDP growth, labor productivity, and R&D spending among other transformations of economies in different nations of the globe. Furthermore, the production of goods and services in the ICT sector is also contributing to the economic growth and development. As per the statistics in the United Nations Conference on Trade and Development’s database, the ICT good exports (% of total good exports) globally grew from 10.816 in 2015 to 11.536 in 2019. In 2019, these exports in Hong Kong SAR, China amounted to 56.65%, 25.23% in East Asia & Pacific, 26.50% in China, 25.77% in Korea, Rep., 8.74% in the United States, and 35.01% in Vietnam. These are some of the important factors that are boosting the growth of the market.

Global Machine Learning in the Pharmaceutical Industry Market Regional Synopsis

On the basis of geographical analysis, the global machine learning in the pharmaceutical industry market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to gain the largest market share throughout the forecast period, owing to the presence of major pharmaceutical companies in the region, along with constant advancements in the medical sector. Moreover, the technological sector in the United States and Canada is also experiencing rapid progress and innovation, which is estimated to encourage the adoption of machine learning in the pharmaceutical industry. The market in Asia Pacific region is estimated to witness modest growth over the forecast period on the back of increasing adoption of AI in developing countries, such as, Japan, China, South Korea, Singapore, and others. The technological advancement in these regions is anticipated to boost the market growth.

Machine Learning in the Pharmaceutical Industry Market

Get more information on this reportDownload Sample PDF

The global machine learning in the pharmaceutical industry market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global machine learning in the pharmaceutical industry market includes the following segments:

By Application

  • Electronic Recordkeeping
  • Data Integrity
  • Predictive Analysis
  • Radiology
  • Others

Growth Drivers

  • Increasing Adoption of Artificial Intelligence
  • Growing Need for Advanced Technology in Medical Sector

Challenges

  • Lack of Resources in the Developing and Under Developed Countries

Top Featured Companies Dominating the Market

  • Biovista Lifesciences
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Cyclica Inc.
  • BioSymetrics Inc.
  • Cloud Pharmaceuticals, Inc.
  • Deep Genomics
  • Atomwise Inc.
  • Alphabet Inc.
  • Nvidia Corporation
  • International Business Machines Corporation
  • Microsoft Corporation

FREQUENTLY ASKED QUESTIONS


Related Reports


Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2021 Research Nester. All Rights Reserved